Rapamycin targets several pathophysiological features of immune-mediated bone marrow failure in murine models.

ABSTRACT:

SUBMITTER: Weston WW 

PROVIDER: S-EPMC5622846 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature